Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.

Pringsheim T, Holler-Managan Y, Okun MS, Jankovic J, Piacentini J, Cavanna AE, Martino D, Müller-Vahl K, Woods DW, Robinson M, Jarvie E, Roessner V, Oskoui M.

Neurology. 2019 May 7;92(19):907-915. doi: 10.1212/WNL.0000000000007467.

PMID:
31061209
2.

Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders.

Pringsheim T, Okun MS, Müller-Vahl K, Martino D, Jankovic J, Cavanna AE, Woods DW, Robinson M, Jarvie E, Roessner V, Oskoui M, Holler-Managan Y, Piacentini J.

Neurology. 2019 May 7;92(19):896-906. doi: 10.1212/WNL.0000000000007466.

PMID:
31061208
3.

Effects of neo-adjuvant chemotherapy for oesophago-gastric cancer on neuro-muscular gastric function.

Sung EZ, Arasaradnam RP, Jarvie EM, James S, Goodyear SJ, Borman RA, Snead D, Sanger GJ, Nwokolo CU.

Mol Biol Rep. 2012 Dec;39(12):9989-94. doi: 10.1007/s11033-012-1866-7. Epub 2012 Jun 29.

PMID:
22744429
4.

Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring.

Jarvie E, Hauguel-de-Mouzon S, Nelson SM, Sattar N, Catalano PM, Freeman DJ.

Clin Sci (Lond). 2010 Apr 28;119(3):123-9. doi: 10.1042/CS20090640.

5.

Characterization of a calcitonin gene-related peptide release assay in rat isolated distal colon.

Kaur R, O'Shaughnessy CT, Jarvie EM, Winchester WJ, McLean PG.

Arch Pharm Res. 2009 Dec;32(12):1775-81. doi: 10.1007/s12272-009-2216-8. Epub 2010 Feb 17.

PMID:
20162407
6.

Obstetric management of obesity in pregnancy.

Jarvie E, Ramsay JE.

Semin Fetal Neonatal Med. 2010 Apr;15(2):83-8. doi: 10.1016/j.siny.2009.10.001. Epub 2009 Oct 31.

PMID:
19880362
7.

The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor.

Bailey JM, Scott JS, Basilla JB, Bolton VJ, Boyfield I, Evans DG, Fleury E, Heightman TD, Jarvie EM, Lawless K, Matthews KL, McKay F, Mok H, Muir A, Orlek BS, Sanger GJ, Stemp G, Stevens AJ, Thompson M, Ward J, Vaidya K, Westaway SM.

Bioorg Med Chem Lett. 2009 Nov 15;19(22):6452-8. doi: 10.1016/j.bmcl.2009.09.027. Epub 2009 Sep 12.

PMID:
19804969
8.

GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motility.

Sanger GJ, Westaway SM, Barnes AA, Macpherson DT, Muir AI, Jarvie EM, Bolton VN, Cellek S, Näslund E, Hellström PM, Borman RA, Unsworth WP, Matthews KL, Lee K.

Neurogastroenterol Motil. 2009 Jun;21(6):657-64, e30-1. doi: 10.1111/j.1365-2982.2008.01270.x.

PMID:
19374732
9.

Discovery of N-(3-fluorophenyl)-1-[(4-([(3S)-3-methyl-1-piperazinyl]methyl)phenyl)acetyl]-4-piperidinamine (GSK962040), the first small molecule motilin receptor agonist clinical candidate.

Westaway SM, Brown SL, Fell SC, Johnson CN, MacPherson DT, Mitchell DJ, Myatt JW, Stanway SJ, Seal JT, Stemp G, Thompson M, Lawless K, McKay F, Muir AI, Barford JM, Cluff C, Mahmood SR, Matthews KL, Mohamed S, Smith B, Stevens AJ, Bolton VJ, Jarvie EM, Sanger GJ.

J Med Chem. 2009 Feb 26;52(4):1180-9. doi: 10.1021/jm801332q.

PMID:
19191554
10.

UDP-glucose modulates gastric function through P2Y14 receptor-dependent and -independent mechanisms.

Bassil AK, Bourdu S, Townson KA, Wheeldon A, Jarvie EM, Zebda N, Abuin A, Grau E, Livi GP, Punter L, Latcham J, Grimes AM, Hurp DP, Downham KM, Sanger GJ, Winchester WJ, Morrison AD, Moore GB.

Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G923-30. doi: 10.1152/ajpgi.90363.2008. Epub 2009 Jan 22.

11.

The discovery of biaryl carboxamides as novel small molecule agonists of the motilin receptor.

Westaway SM, Brown SL, Conway E, Heightman TD, Johnson CN, Lapsley K, Macdonald GJ, MacPherson DT, Mitchell DJ, Myatt JW, Seal JT, Stanway SJ, Stemp G, Thompson M, Celestini P, Colombo A, Consonni A, Gagliardi S, Riccaboni M, Ronzoni S, Briggs MA, Matthews KL, Stevens AJ, Bolton VJ, Boyfield I, Jarvie EM, Stratton SC, Sanger GJ.

Bioorg Med Chem Lett. 2008 Dec 15;18(24):6429-36. doi: 10.1016/j.bmcl.2008.10.072. Epub 2008 Oct 19.

PMID:
19006669
12.

Identification of small molecule agonists of the motilin receptor.

Heightman TD, Conway E, Corbett DF, Macdonald GJ, Stemp G, Westaway SM, Celestini P, Gagliardi S, Riccaboni M, Ronzoni S, Vaidya K, Butler S, McKay F, Muir A, Powney B, Winborn K, Wise A, Jarvie EM, Sanger GJ.

Bioorg Med Chem Lett. 2008 Dec 15;18(24):6423-8. doi: 10.1016/j.bmcl.2008.10.071. Epub 2008 Oct 19.

PMID:
18980843
13.

Potentiation by cholinesterase inhibitors of cholinergic activity in rat isolated stomach and colon.

Jarvie EM, Cellek S, Sanger GJ.

Pharmacol Res. 2008 Nov-Dec;58(5-6):297-301. doi: 10.1016/j.phrs.2008.09.001. Epub 2008 Sep 9.

PMID:
18824231
14.

Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon.

Bassil AK, Borman RA, Jarvie EM, McArthur-Wilson RJ, Thangiah R, Sung EZ, Lee K, Sanger GJ.

Br J Pharmacol. 2008 May;154(1):126-35. doi: 10.1038/bjp.2008.84. Epub 2008 Mar 10.

15.

Synergy between 5-HT4 receptor activation and acetylcholinesterase inhibition in human colon and rat forestomach.

Cellek S, Thangiah R, Jarvie EM, Vivekanandan S, Lalude O, Sanger GJ.

Neurogastroenterol Motil. 2008 May;20(5):539-45. doi: 10.1111/j.1365-2982.2007.01062.x. Epub 2008 Jan 10.

PMID:
18194150
16.

Differences between the abilities of tegaserod and motilin receptor agonists to stimulate gastric motility in vitro.

Jarvie EM, North Laidler VJ, Corcoran S, Bassil A, Sanger GJ.

Br J Pharmacol. 2007 Feb;150(4):455-62. Epub 2007 Jan 8.

17.

5-HT4 receptor agonists enhance both cholinergic and nitrergic activities in human isolated colon circular muscle.

Cellek S, John AK, Thangiah R, Dass NB, Bassil AK, Jarvie EM, Lalude O, Vivekanandan S, Sanger GJ.

Neurogastroenterol Motil. 2006 Sep;18(9):853-61.

PMID:
16918765
18.

Adenosine A(1) receptor-mediated inhibition of protein kinase A-induced calcitonin gene-related peptide release from rat trigeminal neurons.

Carruthers AM, Sellers LA, Jenkins DW, Jarvie EM, Feniuk W, Humphrey PP.

Mol Pharmacol. 2001 Jun;59(6):1533-41.

PMID:
11353815
19.

Optimization of a somatostatin mimetic via constrained amino acid and backbone incorporation.

Souers AJ, Rosenquist A, Jarvie EM, Ladlow M, Feniuk W, Ellman JA.

Bioorg Med Chem Lett. 2000 Dec 18;10(24):2731-3.

PMID:
11133079
20.

Selective somatostatin sst(2) receptor blockade with the novel cyclic octapeptide, CYN-154806.

Feniuk W, Jarvie E, Luo J, Humphrey PP.

Neuropharmacology. 2000 Jun 8;39(8):1443-50.

PMID:
10818260
21.

The solid phase synthesis of a series of tri-substituted hydantoin ligands for the somatostatin SST5 receptor.

Sciciński JJ, Barker MD, Murray PJ, Jarvie EM.

Bioorg Med Chem Lett. 1998 Dec 15;8(24):3609-14.

PMID:
9934480
22.

Molecular cloning and functional characterization of a rat somatostatin sst2(b) receptor splice variant.

Schindler M, Kidd EJ, Carruthers AM, Wyatt MA, Jarvie EM, Sellers LA, Feniuk W, Humphrey PP.

Br J Pharmacol. 1998 Sep;125(1):209-17.

23.

Somatostatin sst2 receptor-mediated inhibition of parietal cell function in rat isolated gastric mucosa.

Wyatt MA, Jarvie E, Feniuk W, Humphrey PP.

Br J Pharmacol. 1996 Nov;119(5):905-10.

24.

Supplemental Content

Loading ...
Support Center